MedWatch

Nuevolution CEO on million-dollar offer from Amgen: "It's the result of many years' work"

CEO in Danish Nuevolution, Alex Gouliaev, credits his employees for Amgen's offer to acquire the company for USD 167 million. He hopes that he and most staff members will continue their work under the new leadership, which is to speed up development in the Danish company.

Photo: Nuevolution PR

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try MedWatch for 14 days.

Get a trial subscription here.

Do you want a trial subscription with multiple users for yourself and your colleagues?

Read more about your options and find the contact information to our sales team here.

Related articles